Oncology Resource Center
Click on the subcategory below to find drug monographs for that particular area.
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
African-American, white Hispanic women more likely to receive non-guideline-concordant treatment
Worse intake patterns than matched individuals from general population for empty calories, fiber
The FDA has approved Opdivo (nivolumab) for the treatment of advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based therapy, and has approved the PD-L1 IHC 28-8 pharmDx test to aid clinicians in determining which patients may benefit most from treatment with Opdivo.
Higher stroke risk found in older kidney cancer patients taking the drugs
Racial disparities associated with use of the procedure for uterine, cervical cancers
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Featured courses from myCME
Led by renowned faculty Program Director Christopher G. Willett, MD, this review focuses on therapies ...
This activity is designed to change health provider attitudes on chronic pain and willingness to ...
Among the many issues clinicians face today, staying current with advances in medicine is becoming ...
- The Vitamin D Debate: Conundrums and Complexities, Part 2
- Clinicians Think Rare Disease But Clinical Clues Lead to Something More Disturbing
- A Rare Case of Ketoacidosis in a Non-Diabetic Patient: What's the Cause?
- CDC Warns of Drug-Resistant 'Superbug' in Multiple U.S. Cities
- Drug Used to Reduce Mortality After MI Discontinued, Generic in Shortage